Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Market Complaint Trending and Evaluation – V 2.0

Posted on By

API Manufacturing: SOP for Market Complaint Trending and Evaluation – V 2.0

Standard Operating Procedure for Market Complaint Trending and Evaluation in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/173/2025
Supersedes SOP/API/173/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a systematic procedure for the trending and evaluation of market complaints received for Active Pharmaceutical Ingredients (APIs), enabling early detection of recurring issues, identification of trends, and implementation of preventive actions.

2. Scope

This SOP applies to all market complaints received by the Quality Assurance Department related to APIs manufactured and distributed from the facility. It covers the collection, analysis,

trending, evaluation, and reporting of complaint data.

3. Responsibilities

  • QA Documentation Cell: Collects and maintains all complaint data and initiates trending reports.
  • QA Officer/Executive: Conducts data analysis and prepares graphical and statistical complaint trend reports.
  • Functional Department Heads: Review complaint trends relevant to their departments and implement CAPA if needed.
  • QA Head: Reviews and approves all trending evaluations, escalates critical issues to management, and ensures inclusion in the Management Review Meeting.
See also  API Manufacturing: SOP for Safety Measures in Solvent Recovery Operations - V 2.0

4. Accountability

The QA Head is accountable for ensuring that all complaints are trended and evaluated periodically and that risk-based actions are implemented to prevent recurrence.

5. Procedure

5.1 Data Collection

  1. QA shall maintain a centralized Market Complaint Register (Annexure-1) where all complaint data is recorded.
  2. Information captured shall include:
    • Complaint number and date
    • Product name and batch number
    • Nature and category of complaint
    • Confirmed/not confirmed status
    • Closure status and date

5.2 Categorization of Complaints

  1. Each complaint shall be categorized into one of the following types:
    • Quality Complaint: Assay failure, impurity deviation, contamination, OOT
    • Packaging Complaint: Labeling error, sealing issue, barcode problems
    • Delivery Complaint: Delay, temperature excursion, transport damage
    • Documentation Complaint: COA error, missing BMR pages, regulatory query
  2. This categorization shall be maintained in the Complaint Trending Log (Annexure-2).

5.3 Trending Frequency and Parameters

  1. Trending shall be conducted:
    • Quarterly – by product, complaint type, and customer
    • Annually – consolidated trend report
  2. Parameters trended include:
    • Total complaints received
    • Confirmed complaints
    • Repeat complaints by product or department
    • Average closure time
    • RCA classification (e.g., human error, equipment failure, supplier-related)
See also  API Manufacturing: SOP for Intermediate Moisture Check using IR Balance - V 2.0

5.4 Trend Analysis

  1. Complaints shall be plotted using bar graphs or Pareto charts (Annexure-3).
  2. Trends shall be evaluated for:
    • Significant increase in complaints
    • Patterns indicating systemic failure
    • Recurring issues from specific customers or regions
  3. If a trend is detected, a detailed investigation shall be initiated via a deviation/CAPA as per site SOP.

5.5 Reporting and Review

  1. Quarterly Complaint Trending Reports shall be compiled by QA and submitted to the QA Head.
  2. These reports shall be discussed in:
    • Internal Quality Review Meetings
    • Annual Product Quality Review (APQR)
    • Management Review Meetings
  3. Summary metrics shall be shared with all relevant departments for awareness and preventive action planning.

5.6 Regulatory Reporting

  1. For critical trends or high-impact complaints, Regulatory Affairs shall be informed to evaluate if market action or agency communication is required.

5.7 CAPA and Continuous Improvement

  1. QA shall track all complaints leading to CAPA in the CAPA Tracker (Annexure-4).
  2. Actions from trending (e.g., training, SOP revision, supplier audit) shall be monitored for closure and effectiveness.

6. Abbreviations

  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • OOT: Out of Trend
  • APQR: Annual Product Quality Review
See also  API Manufacturing: SOP for Reference Standard Qualification and Handling - V 2.0

7. Documents

  1. Market Complaint Register (Annexure-1)
  2. Complaint Trending Log (Annexure-2)
  3. Complaint Trend Charts (Annexure-3)
  4. Complaint CAPA Tracker (Annexure-4)

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR 211.198 – Complaint Files
  • EU GMP Chapter 8 – Complaints and Product Recall

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Market Complaint Register

Complaint No. Date Product Batch No. Type Status
MC/2025/006 01/03/2025 API-X BX2025A Packaging Closed

Annexure-2: Complaint Trending Log

Month Total Quality Packaging Delivery Documentation
March 2025 5 2 1 1 1

Annexure-3: Complaint Trend Chart (Example)

Complaint Type Q1 Q2 Q3 Q4
Quality 3 5 2 4
Packaging 1 2 0 1

Annexure-4: Complaint CAPA Tracker

CAPA No. Related Complaint Action Owner Status
CAPA/2025/010 MC/2025/006 Retrain on label verification QA Closed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP QA Head
14/04/2025 2.0 Included trending formats and CAPA tracking Improved compliance and visibility QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Online Inspection during Injectable Manufacturing – V 2.0
Next Post: BA-BE Studies: SOP for Backup and Archiving of Analytical Data – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version